Condensed Consolidated Statements of Cash Flows - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Cash flows from operating activities:
Net loss			$ (6,280,143)	$ (7,638,987)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization			11,461	634
Stockbased compensation			214,318	285,567
Foreign currency (gain) loss	$ 5,502	$ (56,363)	(50,674)	(42,566)
Changes in operating assets and liabilities:
Prepaid expenses and other current assets			(223,296)	410,246
Accounts payable			(703,473)	289,605
Accrued expenses			(67,470)	499,516
Deferred grant revenue			(478,235)
Net cash used in operating activities			(7,577,512)	(6,195,985)
Cash flows from investing activities:
Purchases of property and equipment			(15,478)
Net cash used in investing activities			(15,478)
Cash flows from financing activities:
Proceeds from issuance of common stock			15,999,598	5,788,918
Common stock issuance costs			(1,310,953)	(648,928)
Net cash provided by financing activities			14,688,645	5,139,990
Change in cash and cash equivalents and restricted cash			7,095,655	(1,055,995)
Effect of exchange rate changes on cash, cash equivalents and restricted cash			(7,238)	(5,341)
Cash, cash equivalents and restricted cash-beginning of year			21,647,537	28,786,647
Cash, cash equivalents and restricted cash-end of period	28,735,954	27,725,311	28,735,954	27,725,311
Reconciliation of cash, cash equivalents and restricted cash
Cash and cash equivalents	28,694,694	27,685,131	28,694,694	27,685,131
Restricted cash	41,260	40,180	41,260	40,180
Total cash, cash equivalents and restricted cash	$ 28,735,954	$ 27,725,311	$ 28,735,954	$ 27,725,311